President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases. 

The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.

"We're going to be able to make that drug available almost immediately," Trump said. 

The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.

He also tempered the president's optimism about the still-untested solution. 

"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."

New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.  

"The therapies are something we could move on much faster potentially," Trump said. 

He claimed the administration "slashed red tape" to develop new vaccines and therapies.

The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks

"If we find that we need something, then we will do that," he said.  

Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak. 

The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.

"We continue our relentless effort to defeat the Chinese virus," Trump said.

Share:
More In Politics
Biden Vows No Nord Stream 2 if Russia Invades Ukraine
In a flurry of diplomacy across two continents, President Joe Biden emerged from a meeting with Germany’s new leader to vow the crucial Nord Stream 2 gas pipeline in Europe would be blocked if Russia further invades Ukraine.
New SEC Proposal Could Lead to Sweeping Regulation for Crypto
Jarrod Loadholt, Partner at Ice Miller, joins Cheddar News' Closing Bell, where he breaks down the latest proposal by the SEC and explains how it could allow the agency to make major regulatory moves within the cryptocurrency space if approved.
Caden Raises $3.4M in Pre-Seed Funding to Allow Users to Monetize Personal Data
Personal data platform Caden raised $3.1 million in pre-seed funding. Caden says its service allows users to have complete control over their data and earn a profit from it by sharing certain data with trusted brands, while never relinquishing ownership. The company also says its goal is to transform the internet and the use of personal data and make a better system for both consumers and brands. Caden founder and CEO John Roa joins Cheddar News' Closing Bell to discuss.
U.S. Economy Defies Omicron, Adds 467,000 Jobs in January
U.S. employers stepped up hiring in January, adding 467,000 jobs despite a wave of omicron inflections that sickened millions of workers, kept many consumers at home and left businesses from restaurants to manufacturers short-staffed.
Winter Storm Packing Snow, Freezing Rain Moves Across U.S.
A major winter storm with millions of Americans in its path brought a mix of rain, freezing rain and snow to the middle section of the United States as airlines canceled hundreds of flights, governors urged residents to stay off roads and schools closed campuses.
Load More